Hancock Jaffe Laboratories Inc Current ratio
Was ist das Current ratio von Hancock Jaffe Laboratories Inc?
Current ratio von Hancock Jaffe Laboratories Inc ist 29.74
Was ist die Definition von Current ratio?
Das derzeitige Verhältnis ist ein Liquiditätsgrad das misst, ob ein Unternehmen über ausreichende Ressourcen verfügt, um seine kurzfristigen Verpflichtungen zu erfüllen.
The current ratio is an indication of a company's liquidity and measures the capability to meet a company's short-term obligations. It compares a firm's current assets to its current liabilities, and is expressed as current assets divided by current liabilities. The ratio is only useful when two companies are compared within industry because inter industry business operations differ substantially. To determine liquidity, the current ratio is not as helpful as the quick ratio, because it includes all those assets that may not be easily liquidated, like prepaid expenses and inventory.
Acceptable current ratios vary from industry to industry. In many cases an investor would consider a high current ratio to be better than a low current ratio, because a high current ratio indicates that the company is more likely to pay the investor back. Large current ratios are not always a good sign for investors. If the company's current ratio is too high it may indicate that the company is not efficiently using its current assets or its short-term financing facilities. If current liabilities exceed current assets the current ratio will be less than 1. A current ratio of less than 1 indicates that the company may have problems meeting its short-term obligations.
Some types of businesses can operate with a current ratio of less than one however. If inventory turns into cash much more rapidly than the accounts payable become due, then the firm's current ratio can comfortably remain less than one. Inventory is valued at the cost of acquiring it and the firm intends to sell the inventory for more than this cost. The sale will therefore generate substantially more cash than the value of inventory on the balance sheet. Low current ratios can also be justified for businesses that can collect cash from customers long before they need to pay their suppliers.
Current ratio von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Hancock Jaffe Laboratories Inc
Was macht Hancock Jaffe Laboratories Inc?
Hancock Jaffe Laboratories specializes in developing and manufacturing bioprosthetic (tissue-based) medical devices to establish improved standards of care for treating cardiac and vascular diseases. HJLI currently has two lead product candidates: the VenoValveÒ, a porcine-based valve which is intended to be surgically implanted in the deep venous system of the leg to treat reflux associated with Chronic Venous Insufficiency, and the CoreoGraftÒ, a bovine tissue-based off-the-shelf conduit intended to be used for coronary artery bypass surgery.
Unternehmen mit current ratio ähnlich Hancock Jaffe Laboratories Inc
- Syncora hat Current ratio von 29.57
- TTL Beteiligungs & Grundbesitz AG hat Current ratio von 29.57
- Fosterville South Exploration hat Current ratio von 29.63
- Tambourah Metals hat Current ratio von 29.67
- European Metals hat Current ratio von 29.71
- 4DS Memory hat Current ratio von 29.74
- Hancock Jaffe Laboratories Inc hat Current ratio von 29.74
- Sentinel Resources hat Current ratio von 29.76
- Riley Gold Corp hat Current ratio von 29.78
- Energiser Investments plc hat Current ratio von 29.80
- Drumz plc hat Current ratio von 29.80
- CytoTools AG hat Current ratio von 29.85
- King River Resources hat Current ratio von 29.90